Circulating tumor DNA methylation marker-based minimal residual diseases detection and recurrence monitoring of cancer

被引：0
|
作者：
Wang, Huiyong
Pan, Xiaobao
Wang, Lin
Li, Chao
Ma, Chao
Yu, Shuai
Meng, Fanyang
Liu, Jing
Liu, Liang
Cao, Zhanbo
机构：
[1] Smartquerier Gene Technol Shanghai Co Ltd, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Pancreat Surg, Shanghai, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15172
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer
    Wu-Hao Lin
    Jian Xiao
    Zi-Yi Ye
    Da-Liang Wei
    Xiao-Hui Zhai
    Rui-Hua Xu
    Zhao-Lei Zeng
    Hui-Yan Luo
    Clinical Epigenetics, 2021, 13
  • [22] The application of circulating tumor DNA analysis for detecting minimal residual disease and predicting recurrence in colorectal cancer patients
    Chan, Hiu Ting
    Nagayama, Satoshi
    Chin, Yoon Ming
    Hayashi, Rie
    Kiyotani, Kazuma
    Nakamura, Yusuke
    Low, Siew-Kee
    CANCER RESEARCH, 2019, 79 (13)
  • [23] Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
    Xu, Fei
    Yu, Shanshan
    Han, Junyi
    Zong, Ming
    Tan, Qi
    Zeng, Xin
    Fan, Lieying
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (08) : E00386
  • [24] Circulating tumor DNA as a marker of minimal residual disease following local treatment of metastases from colorectal cancer
    Boysen, Anders K.
    Pallisgaard, Niels
    Andersen, Christina S. A.
    Spindler, Karen-Lise G.
    ACTA ONCOLOGICA, 2020, 59 (12) : 1424 - 1429
  • [25] Methylation profiling of circulating tumor DNA for the detection of ovarian cancer
    Ning Li
    Yu Zhang
    Xin Zhu
    Zhang, Zhenjing
    Xu, Jiayue
    Li, Bingsi
    Han Han-Zhang
    Qiu, Fujun
    Shuai Fang
    Hao Liu
    Zhang, Zhihong
    CANCER RESEARCH, 2020, 80 (16)
  • [26] Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients
    Mishima, Chieko
    Kagara, Naofumi
    Matsui, Saki
    Tanei, Tomonori
    Naoi, Yasuto
    Shimoda, Masafumi
    Shimomura, Atsushi
    Shimazu, Kenzo
    Kim, Seung Jin
    Noguchi, Shinzaburo
    SPRINGERPLUS, 2015, 4
  • [27] Development of customized circulating tumor DNA panel for minimal residual disease detection in biliary tract cancer
    Shinohara, Yoshihito
    Low, Siew-Kee
    Nakamura, Toru
    Kimura, Yasutoshi
    Murakami, Takeshi
    Kiyotani, Kazuma
    Hirano, Satoshi
    CANCER RESEARCH, 2024, 84 (06)
  • [28] A retrospective study of circulating tumor DNA for minimal residual disease detection in the management of colorectal cancer.
    Storandt, Michael H.
    Emiloju, Oluwadunni Eunice
    Zemla, Tyler J.
    McWilliams, Robert R.
    Sinicrope, Frank A.
    Mitchell, Jessica L.
    Shi, Qian
    Jin, Zhaohui
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 227 - 227
  • [29] Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer
    Azad, Tej D.
    Chaudhuri, Aadel A.
    Fang, Penny
    Qiao, Yawei
    Esfahani, Mohammad S.
    Chabon, Jacob J.
    Hamilton, Emily G.
    Yang, Yi D.
    Lovejoy, Alex
    Newman, Aaron M.
    Kurtz, David M.
    Jin, Michael
    Schroers-Martin, Joseph
    Stehr, Henning
    Liu, Chih Long
    Hui, Angela Bik-Yu
    Patel, Viren
    Maru, Dipen
    Lin, Steven H.
    Alizadeh, Ash A.
    Diehn, Maximilian
    GASTROENTEROLOGY, 2020, 158 (03) : 494 - +
  • [30] The Method of Minimal Residual Disease Detection With Circulating Tumor DNA and Its Clinical Applications in Colorectal Cancer
    Liu, Ming
    Mu, Tianhao
    Gu, Jia
    Xu, Mingyan
    Chen, Shifu
    CANCER REPORTS, 2025, 8 (03)
12345